Kent E. Lieginger
Director/Board Member at University of the Sciences in Philadelphia
Profile
Kent E.
Lieginger is an Independent Director at Achaogen, Inc. and a Trustee at the University of the Sciences in Philadelphia.
He was previously a Director at The Genentech Foundation from 2005 to 2012, and SVP-Managed Care & Customer Operations at Genentech, Inc. from 2010 to 2014.
He also held positions as Vice President at GSK Plc and Assistant Professor at the University of California.
Kent E. Lieginger active positions
| Companies | Position | Start |
|---|---|---|
| University of the Sciences in Philadelphia | Director/Board Member | 2012-12-31 |
Former positions of Kent E. Lieginger
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2014-06-30 |
| The Genentech Foundation | Director/Board Member | 2011-12-31 |
| University of California | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
| ACHAOGEN | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
| The Genentech Foundation | Miscellaneous |
- Stock Market
- Insiders
- Kent E. Lieginger
